oms906
·Code: OMS906
oms906: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| OMEROS CORP (OMER) | Phase 2 |
Clinical Trials (1)
A Phase 2 Proof of Concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of OMS906 in PNH Patients With a Sub-optimal Response to the C5 Inhibitor, Ravulizumab
Frequently asked questions
Who is developing oms906?
oms906 is being developed by OMEROS CORP.
How many clinical trials involve oms906?
BioSniper tracks 1 clinical trial involving oms906.
Get deeper analysis on oms906
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis